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Hormonal responses to acute volume changes in anephric subjects. The
response of plasma aldosterone and cortisol concentrations to acute
volume depletion was studied in 18 chronically anephric subjects and
four recently nephrectomized subjects. Volume-depleting hemodialysis
and hemodialysis without volume depletion produced insignificant
changes in plasma aldosterone concentrations in chronically anephric
subjects. Failure of volume depletion to increase plasma aldosterone
concentrations in these subjects could not be attributed to reductions in
plasma potassium concentrations and was in marked contrast to the
effect on plasma cortisol concentrations, which increased significantly
during volume depletion. Changes in plasma cortisol concentrations
exhibited a negative correlation with changes in diastolic blood pressure
(r =
—0.712, P < 0.001) and were shown to correspond to similar
changes in plasma ACTH concentrations. Comparable increases in
plasma cortisol and ACTH concentrations were also demonstrated in
the studies on recently nephrectomized subjects, who, in contrast to
chronically anephric subjects, exhibited increases in plasma aldoster-
one concentrations which were concordant with the changes in plasma
cortisol and ACTH concentrations. These findings suggest that plasma
aldosterone concentrations are regulated by a volume-sensitive mecha-
nism in recently nephrectomized subjects but not in chronically aneph-
nc subjects. We interpret these data as evidence of aldosterone
responsiveness to ACTH that persists for a limited time only after
removal of the stimulus provided by the renin-angiotensin system.
Volume-related changes in plasma cortisol and ACTH concentrations
occur in the absence of stimulation by a functioning renin-angiotensin
system.
Réponses hormonales a des modifications aiguës volemiques chez des
sujets anephriques. La réponse des concentrations plasmatiques d'al-
dostérone et de cortisol a une déplétion volemique aiguë a été étudiée
chez 18 sujets anephriques chroniques et chez quatre sujets récemment
nephrectomises. Une hemodialyse avec depletion volemique et une
hemodialyse sans depletion volémique ont entralné des modifications
non significatives des concentrations d'aldostérone plasmatique chez
les sujets anephriques chroniques. L'absence d'augmentation des con-
centrations d'aldostérone plasmatique lors de la depletion volemique
chez ces malades ne pouvait pas étre attribuee a des diminutions des
concentrations potassiques plasmatiques et était en opposition marquee
avec l'effet sur Ia cortisolémie, qui s'est élevée significativement
pendant Ia depletion volemique. Les modifications de la cortisolemie
etaient correlees negativement avec les modifications de Ia pression
arterielle diastolique (r = —0,712, P < 0,001), et il a ete montré qu'elles
correspondaient a des modifications similaires des concentrations plas-
matiques d'ACTH. Des augmentations comparables des concentrations
plasmatiques de cortisol et d'ACTH ont egalement ete demontrees dans
l'étude de sujets récemment nephrectomises, lesquels, par opposition
avec les sujets anephriques chroniques, avaient des augmentations des
concentrations d'aldosterone plasmatique qui etaient concordantes
avec les modifications des concentrations plamatiques de cortisol et
d'ACTH. Ces résultats suggèrent que les concentrations d'aldostérone
sont regulees par un mécanisme sensible au volume chez les sujets
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récemment nephrectomises, mais non chez les sujets anéphriques
chroniques. Nous interprétons ces donnees comme une preuve de Ia
reponse de l'aldostérone a I'ACTH qui persiste seulement pendant un
temps limité aprés suppression du stimulus que realise le système
rénine-angiotensine. Des modifications liées au volume des concentra-
tions plasmatiques de cortisol et d'ACTH surviennent en l'absence de
stimulation par un système renine-angiotensine fonctionnel.
The role of the renin-angiotensin system in the response of
aldosterone secretion to volume changes is well-documented
[1—91. There is still uncertainty, however, regarding the
role of other volume-sensitive mechanisms in this response.
Putative volume-related changes in plasma aldosterone concen-
tratioris in anephric subjects were reported by Mitra et al [101,
Weidmann et al [111, McCaa et at [12], Read et al [131, and
McCaa et al [14], but none of the evidence presented in these
reports clearly identifies the mechanism(s) for such changes.
Although ACTH-mediated stimulation of aldosterone secretion
has been postulated as an explanation for these changes, studies
clearly relating changes in plasma aldosterone concentration to
volume-related changes in plasma ACTH concentration have
not been reported. The studies presented in this report
were undertaken in part to document more clearly the behavior
of plasma aldosterone concentration in relation to volume
changes in anephric subjects and to assess systematically the
effects of plasma potassium concentration and ACTH on this
behavior.
Stimulation of cortisol secretion by volume depletion [15—211
has been attributed to mechanisms that involve changes in the
activity of cardiovascular baroreceptors that send impulses
along afferent neural pathways to the hypothalamus to regulate
ACTH secretion [18—20, 22, 23]. It has also been suggested that
angiotensin II, generated during acute volume depletion, may
increase cortisol secretion by acting either directly on the
adrenal cortex or through stimulation of ACTH secretion [24—
261. The need to clarify these relationships provided an addi-
tional impetus for these studies.
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Methods
All studies were performed on anephric subjects treated by
intermittent hemodialysis. Eighteen subjects were chronically
anephric and four subjects were studied in the early postneph-
reetomy period. Studies were performed one or more times on
all subjects following an overnight fast, which was extended to
include a 6- or 7-hr period of hemodialysis beginning at approxi-
mately 7:30 AM. Blood pressure was carefully monitored
throughout the studies, and subjects who developed sympto-
matic hypotension were treated promptly by intravenous ad-
ministration of 0.155 M sodium chloride, Informed consent was
obtained from all subjects, who were subsequently divided into
four groups in accordance with the following protocols:
Group I. Volume-depleting hemodialysis and volume-stable
hemodialysis
The effects of volume-depleting hemodialysis and hemodialy-
sis without volume depletion were compared in studies on six
chronically anephric subjects, four females and two males. The
age range of these subjects was 16 to 40 years. The interval
between nephrectomy and the studies varied from 4 o 30
months.
In the volume-depletion studies, the subjects were weighed
prior to and after the completion of hemodialysis, and 0.155 M
sodium chloride was administered only as required to correct
substantial reductions in blood pressure. In the volume-stable
studies, measurements of body weight were obtained every 15
mm during hemodialysis by using a metabolic scale (Brookline
Instrument Co., Model 30N, Elmsford, New York) positioned
under the subjects' bed. Sodium chloride (0.155 M) was admin-
istered intravenously as required to keep the body weight
constant. Dialysate potassium concentration was 2.0 mEq/liter
in both studies.
Group 2. Volume-depleting hemodialysis with stable plasma
potassium concentration
Volume-depletion studies identical to those described above,
except that the dialysate potassium concentration was in-
creased to between 4.0 and 5.0 mEq/liter, were performed on
eight chronically anephric subjects, seven females and one male
in the age range of 20 to 42 years. The interval between
nephrectomy and the studies on these subjects varied from 2 to
46 months.
Group 3. Volume-depleting hemodialysis resulting in large
volume reductions
Volume-depletion studies with determinations of 1-hr inte-
grated plasma aldosterone and cortisol concentrations prior to
hemodialysis and during the third and seventh hours of hemodi-
alysis were performed on six hypervolemie, chronically aneph-
nc subjects, four females and two males, ranging in age from 21
to 52 years. The interval between nephrectomy and the studies
varied from 23 to 47 months. Dialysate potassium concentration
was 2.0 mEq/liter.
Group 4. Hemodialysis with hourly assessment of' plasma
hormone concentrations in chronically anephric suljects and
recently nephrectoinized subjects
Studies in which blood samples were obtained hourly during
hemodialysis for the determination of integrated plasma aldos-
terone, cortisol, and ACTH concentrations were performed on
three female, chronically anephric subjects nephrectomized 7, 9
and 19 months prior to the studies, respectively, and on four
subjects (three females and one male) nephrectomized 2 to 10
days before the studies. The age range of these subjects was 24
to 50 years. Dialysate potassium concentration was 2.0 mEq!
liter. The magnitude and rapidity of volume depletion varied,
depending upon clinical indications, and in the studies on one
recently nephrectomized subject, volume depletion was not
attempted. Body weight was measured prior to and at the end of
each hour of hemodialysis. Blood pressure was measured
frequently throughout the studies, and 0.155 M sodium chloride
was administered intravenously as needed to treat episodes of
hypotension.
Collection and handling of blood samples
In the studies on groups I and 2 subjects blood samples for
the determination of plasma aldosterone, cortisol, sodium and
potassium concentrations were collected in heparinized sy-
ringes immediately prior to hemodialysis and after 1, 4 and 7 hr
of hemodialysis. Blood for determination of 1-hr integrated
plasma aldosterone and cortisol concentrations in the studies on
group 3 subjects and plasma aldosterone, cortisol and ACTH
concentrations in the studies on group 4 subjects was with-
drawn continuously into chilled syringes using a Harvard pump
(Harvard Apparatus Company, Millis, Massachusetts). Blood
for determination of plasma sodium and potassium concentra-
tions in these studies was obtained at the midpoint of each 1-hr
sampling period. Blood for the determination of plasma renin
activity (PRA) was collected in chilled syringes containing
EDTA prior to hemodialysis in all studies and hourly during
hemodialysis in the studies on recently nephreetomized sub-
jects. All blood samples were promptly centrifuged at 4°C, and
the separated plasma was frozen and stored for subsequent
analysis. Blood was also obtained prior to and after the comple-
tion of hemodialysis for hematocrit determinations.
Analytical Methods. The methods used in the determination
of plasma renin activity and plasma aldosterone concentration
were described in previous reports [27—29]. Plasma cortisol
concentration was determined by the competitive protein-
binding radioassay of Hsu and Bledsoe [30]. Plasma ACTH
concentration was measured by a modification of the radio-
immunoassay described by Rees et al 131] and Grizzle et al 1321
using an antibody that is 100% cross-reactive with synthetic I-
24, 1-39, and 11-24 ACTH. No cross-reactivity of this antibody
with 1-19 ACTH, aMSH, I3MSH, or 25-39 ACTH was demon-
strated. Interassay and intra-assay coefficients of variation are
10 and 6%, respectively, and the lower limit of sensitivity is 5
pg. Nothing measurable by the assay as ACTH was detected in
plasma from dogs and cats that had undergone anatomically
satisfactory hypophysectomy. Plasma sodium and potassium
concentrations were determined by autoanalyzer flame
photometry.
The significance of changes in the various parameters mea-
sured in each group of subjects was determined by Student's
test for paired variates. Correlations were assessed by linear
regression analysis where appropriate.
Results
Group 1. Volume-depleting hemodialysis and volume-stable
hemodialysis
No quantifiable PRA could be detected in any of the anephric
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Table 1. Plasma potassium, aldosterone and cortisol concentrations prior to (Pre) and after 1 (HI), 4 (H4) and 7 (H7) hr of hemodialysis with
volume depletion (dialysate potassium concentration, 2.0 mEq/liter)
Potassium Aldosterone Cortisol
.Patient
no.
mEqiliter ngldl tg/dl
Body wt
kgPre Hi H4 H7 Pre HI H4 H7 Pre Hl H4 H7
1 4.6 3.8 3.1 2.8 1.8 1.6 1.5 1.5 11.5 9.5 15.0 14.6 —2.6
2 5.5 4.7 3.6 2.9 3.7 2.1 3.0 2.7 9.1 6.8 3.6 12.2 —1.23 4.8 3.9 2.6 2.9 4.4 3.5 2.5 1.0 4.9 7.9 9.2 6.8 —2.5
4a 5.5 3.8 2.7 2.6 4.4 3.0 0.8 1.2 4.8 2.2 6.4 26.2 —2.3
5 5.6 3.7 4.2 4.3 6.4 3.4 2.1 3.4 14.4 11.3 6.1 10.4 —3.9
6 4.9 3.8 3.4 2.8 3.3 2.4 1.9 0.8 11.9 7.6 12.3 8.4 —2.1
Mean 5.2 4.0 3.3 3.1 4.0 2.7 2.0 1.8 9.4 7.6 8.8 13.1 —2.4
SEM ±0.2 ±0.2 ±0.3 ±0.3 ±0.7 ±0.3 ±0.3 ±0.5 ±1.8 ±1.4 ±1.9 ±3.1 ±0.4
a Patien ts are male.
Table 2. Plasma potassium, aldosterone and cortisol concentrations prior to (Pre) and after 1 (Hi), 4 (H4) and 7 (H7) hr of hemodialysis
without volume depletion (dialysate potassium concentration, 2.0 mEq/liter)
Potassium Aldosterone Cortisol
Patient
no.
mEqlliter ngldl ,ag/dl
Body wtkg PreHi H4 H7 Pre Hl H4 H7 Pre Hi H4 H7
1 4.9 3.9 2.6 2.7 3.6 3.4 1.6 0.5 16.0 11.0 15.4 8.8 +0.1
2 5.8 4.6 2.9 2.6 2.8 3.1 1.8 0.9 10.9 9.1 3.9 1.8 +0.2
3a 4.7 3.7 2.6 3.3 1.9 3.4 1.3 1.9 8.2 6.6 8.4 3.9 +0.2
4a 6.2 4.2 3.1 2.7 4.2 3.8 2.6 2.0 3.8 2.7 2.0 10.5 0
5 5.3 4.7 3.9 3.0 3.5 2.6 0.9 0.5 9.3 6.0 7.6 6.7 0
6 5.3 4.5 3.3 2.4 3.7 2.0 0.8 2.5 10.2 7.7 8.9 9.8 +0.1
Mean 5.4 4.3 3.1 2.8 3.3 3.1 1.5 1.4 9.7 7.2 7.7 6.9 +0.08
SEM ±0.2 ±0.2 ±0.2 ±0.1 ±0.4 ±0.3 ±0.3 ±0.4 ±1.8 ±1.3 ±2.1 ±1.5 ±0.03
a Patien ts are male.
subjects on this or other protocols in these studies. Plasma
potassium, aldosterone, and cortisol concentrations prior to
and during 7 hr of volume-depleting hemodialysis, and in
studies performed without volume depletion on the same sub-
jects, are shown in Tables 1 and 2. Plasma potassium and
aldosterone concentrations decreased and were significantly
correlated (P < 0.001) in both studies (r = +0.756 and +0.682
with and without volume depletion, respectively). No signifi-
cant difference in plasma aldosterone concentrations between
volume-depleted and volume-stable subjects could be demon-
strated. Mean reduction in body weight in the volume-depletion
studies was 2.4, 5EM ± 0.4 kg.
Changes in plasma cortisolconcentration were not statistical-
ly significant. However, substantial increases in plasma cortisol
concentration occurred during the volume-depletion studies on
four subjects.
There were no significant changes in plasma sodium concen-
trations. The hematocrit increased 14% in the volume-depletion
studies and did not change significantly during the volume-
stable studies.
Group 2. Volume-depleting hemodialysis with stable plasma
potassium concentration
Plasma potassium, aldosterone and cortisol concentrations
prior to and during 7 hr of hemodialysis with increased dialysate
potassium concentration are shown in Table 3. Plasma potassi-
um and sodium concentrations were not significantly changed,
nor were plasma aldosterone concentrations, despite substan-
tial volume depletion (mean reduction in body weight = 3.2,
SEM ± 0.3 kg). In contrast, plasma cortisol concentrations
increased markedly in some subjects. Examination of the data
from all subjects shows a highly significant negative correlation
(r = —0.712, P < 0.001) between changes in plasma cortisol
concentration after 1, 4 and 7 hr of hemodialysis and the
maximal changes in diastolic blood pressure in the intervals
between sampling relative to predialysis plasma cortisol con-
centration and diastolic blood pressure, respectively (Fig. 1).
Group 3. Volume-depleting hemodialysis resulting in large
volume reductions
Mean reduction in body weight was 4.6, SEM ± 0.8 kg (Table
4). There were no significant changes in plasma sodium concen-
trations. Plasma potassium concentration decreased from 4.9,
SEM ± 0.2 mEq/liter to 3.4, SEM ± 0.2 mEq/liter (P < 0.001),
and the mean I-hr integrated plasma aldosterone concentration,
which was 2.8, SEM ± 0.3 ng/dl prior to hemodialysis, was 2.4,
SEM + 0.4 ng/dl in the seventh hour of hemodialysis. Plasma
cortisol concentration increased significantly in both the third
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Patient
no. Pre 1-Il
7 4.0 5.1
8 4.6 4.3
9 6.1 6.0
lO 4,1 4.0
ha 6.5 5.2
12 5.1 4.5
13 4.7 4.8
5 4.4 4.0
4.6 4.3 4.3
5.0 4.2 11.8
5.0 5.2 17.1
4.2 4.0 6.5
5.0 5.7 6.4
4.4 4.5 5.0
4.9 4.9 6.0
4.1 4.5 4.6
6.3 5.9 4.7 4.5 10.6 17.2 14.3 16.215 3.2
a Patient is male.
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A Diastolic blood pressure, mm Hg
Fig. 1. Correlation between changes in plasma cortisol concentration
and maximal changes in diastolic blood pressare relative to predialysis
plasma cortkcol concentrotion and diastolic blood pressure, respective-
ly, in group 2 subjects.
(P c 0.025) and seventh (P < 0.05) hours of hemodialysis
compared to the predialysis concentration. Patients numbered 8
and 15, whose third-hour integrated plasma cortisol concentra-
tion was substantially higher than either the predialysis or
seventh-hour concentrations, developed symptomatic hypoten-
sion requiring sodium chloride administration during the third
hour.
Group 4. Hemodialysis with hourly assessment of plasma
hormone concentrations in chronically anephric subjects and
recently nephrectomized subjects
Data from each of the studies on chronically anephric sub-
jects and recently nephrectomized subjects are shown in Fig-
ures 2 and 3, respectively. In patients 16 and 17 of the
chronically anephric subjects plasma cortisol and ACTH con-
centrations increased as body weight and blood pressure were
reduced. No increase in plasma cortisol and ACTH concentra-
tions occurred in the studies on one chronically anephric
suhjeet (patient 18) who exhibited only minor changes in body
weight until the final hour of hemodialysis. Plasma cortisol and
ACTH concentrations that were lower at the end than at the
beginning of the studies on this subject are consistent with
diurnal variation. Plasma aldosterone concentrations remained
low and unchanged in all three of these subjects.
Reductions in body weight and blood presstire were also
accompanied by increases in plasma cortisol and ACTH con-
centrations in recently nephreetomized subjects. However, in
contrast to chronically anephric subjects, the recently nephrec-
tomized subjects exhibited increases in plasma aldosterone
concentrations that were concurrent with the increases in
plasma cortisol and ACI'H concentrations. A relationship be-
tween the rapidity of volume depletion and the magnitude of the
associated hormonal responses is suggested by the large in-
creases in plasma cortisol, ACTH and aldosterone concentra-
tions in patients 19 and 20 compared to those observed in the
studies on patient 21. Hemodialysis without volume depletion
in one recently nephrectomized subject (no. 22), was not
associated with significant changes in plasma cortisol and
ACTH concentrations, and plasma aldosterone concentrations,
after a reduction from 4.8 to 0.6 ng/dl in the first 2 hr of
hemodialysis, remained low.
Differences in the magnitude and rapidity of volume deple-
tion, and the absence of volume depletion in the studies on
patient no. 22, make it difficult to determine whether or not the
duration of time between nephrectomy and the studies may
have influenced the response of plasma aldosterone concentra-
tion to volume depletion. However, changes in plasma aldoster-
one concentrations corresponded more closely to the changes
in plasma cortisol and ACTH concentrations in the studies on
patient no. 19 (2 days postnephreetomy) than in the studies on
patient no. 20(8 days postnephrectomy). Studies on subjects 21
and 22 were performed 9 and 10 days postnephrectomy,
respectively.
Prenephrectomy PRA in the recently nephreetomized sub-
jects was 0.4 to 2.8 ngjml/hr prior to volume-depleting hemodi-
Table 3. Plasma potassium, aldosterone and cortisol concentrations prior to (Pre) and after I (HI), 4 (H4) and 7 (H7) hr of hemodialysis with
increased dialysate potassium concentration (4.0 to 5.0 mEqjliter)
Potassium Aldosterone Cortisol
mEq/liter ngldl ,ig/dl
_______ _______ - —------- Bodywt
H4 H7 Prc HI H4 H7 Pre HI H4 H7 kg
1.8 3.5 0.5 17.3 4.9 10.3 18.6 —4.1
2.2 0.7 0.6 11.3 7.2 11.4 15.6 —2.5
13.2 13.1 12.0 7.6 32.8 31.2 30.4 —3.0
6.0 6.7 5.5 9.8 20.0 9.6 12.8 —3.1
7.2 7.1 8.5 9.2 7.2 6.5 10.5 —4.3
8.3 0.5 0.5 7.9 9.9 9.4 15.5 —3.6
5.9 4.6 6.1 11.9 20.0 18.9 15.9 —2.0
2.4 1.0 2.5 10.1 25.4 16.9 10.4 —2.7
Mean 4.9 4.7 4.7 4.7
5EM
+30-
+20-
+10 -
—3.2
r=- —0112
P c 0001
y = 0.533 — 0.285x
:9
:1.
2
0a
a
0-1
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Table 4. One-hour integrated plasma aldosterone and cortisol concentrations prior to (Pre) and during the third (H3) and seventh (H7) hours of
hemodialysis resulting in large volume reductions
.Patient
no.
Aldosterone
ngldl
Pre
Cortisol
pgIdl
H3 H7
Body wt
kg
Pre H3 H7 Pre H3 H7 (Pre-H7)
14a 2.0 2.7 3.2 7.1 12.7 13.1 74.4 71.4 69.2 —5.2
7 4.1 2.3 3.1 9.6 13.9 16.3 61.6 57.1 54.2 —7.4
8 3.0 3.9 2.9 10.6 18.4 14.0 74.8 71.9 72.2 —2.6
5 2.9 — 1.5 8.8 8.7 12.7 72.0 69.1 67.3 —4.7
15 2.0 1.7 1.4 10.1 21.1 12.9 59.8 57.6 57.1 —2.7
ha 2.8 2.4 2.1 10.0 12.2 8.0 64.4 62.3 59.2 —5.2
Mean 2.8 2.6 2.4 9.4 14.5 12.8
—4.6
SEM ±0.3 ±0.4 ±0.4 ±0.6 ±2.0 ±1.2 ±0.8
a Patients are male.
alysis, and increased to 1.5 to 5.1 ng/ml/hr during volume
depletion. At the time of the postnephrectomy studies, PRA
was minimal or absent, and could not be quantified.
Discussion
The central role of the renin-angiotensin system in the
regulation of aldosterone secretion has been demonstrated
clearly in numerous studies [1—91. However, aldosterone secre-
tion persists in anephric subjects and responds to relatively
minor changes in plasma potassium concentration [11, 27, 33,
34]. Studies reported by Mitra et al [10] suggested that plasma
aldosterone concentrations in anephric subjects could be in-
creased by volume-related stimuli that increase plasma cortisol
concentrations. Increases in plasma aldosterone concentrations
in anephric subjects associated with upright posture and ambu-
lation were reported subsequently by Weidmann et al [11].
Other investigators have reported studies showing either no
increase in plasma aldosterone concentration associated with
upright posture in anephric subjects [33, 35—37] or changes in
concentration that were correlated with concomitant occurring
changes in plasma potassium concentration [341.
McCaa et al [12], Read et al [13], and McCaa et al [14]
reported that plasma aldosterone concentrations increased in
anephric subjects who were sodium- and volume-depleted
acutely by hemodialysis. In subsequent studies, however, these
investigators noted that plasma aldosterone concentrations in
anephric subjects were not increased by ultrafiltration and
hemodialysis in the absence of substantial reductions in plasma
sodium concentration [36]. Similarly, Williams et al reported
that plasma aldosterone concentrations in anephric subjects
were not increased by isonatremic volume depletion produced
by hemodialysis despite a 2.0-kg mean reduction in body weight
[35]. In studies on anephric children (2 to 13 months postneph-
rectomy), Birkhäuser et al found that plasma aldosterone
concentrations were not increased by volume-depleting hemo-
dialysis or change from supine to upright posture and could not
be correlated with plasma cortisol concentrations [37]. The
observations in our studies on chronically anephric subjects
agree in essence with these findings.
In contrast, plasma aldosterone concentrations in our studies
on recently nephrectomized subjects increased during volume
depletion and were concordant with observed changes in plas-
ma cortisol and ACTH concentrations. Plasma renin activity,
which falls rapidly after bilateral nephrectomy [38—42], was
absent or below a quantifiable level in all subjects. Stimulation
of aldosterone secretion by ACTH during volume depletion was
suggested by studies on normal subjects reported by Gaillard et
al [43]. Volume depletion following ethacrynic acid administra-
tion resulted in marked increases in plasma aldosterone and
cortisol concentrations in subjects receiving constant infusions
of angiotensin II to inhibit renin release and endogenous
angiotensin II production. In contrast, only slight increases in
plasma aldosterone concentrations, and no increase in plasma
cortisol concentrations, occurred following ethacrynic acid
administration when dexamethasone and angiotensin II were
both infused during the studies. Our studies on recently
nephrectomized subjects also suggest that ACTH plays a role in
the stimulation of aldosterone secretion during volume deple-
tion. However, the absence of increases in plasma aldosterone
concentrations in chronically anephric subjects, despite in-
creases in plasma cortisol and ACTH concentrations, suggests
that responsiveness of aldosterone secretion to ACTH persists
for a limited time only in the absence of continued stimulation
by angiotensin II.
In studies reported by Goodwin, James, and Peart [44], an
increase in plasma aldosterone concentration was demonstrated
after volume-depleting peritoneal dialysis in only one of five
anephric subjects, and this subject had been nephrectomized 10
days before the studies. It was also noted in these studies that
changes in plasma aldosterone concentration produced by
intravenously administered ACTH diminished with time after
nephrectomy. Diminution or absence of aldosterone secretory
responsiveness to ACTH in chronically anephric subjects is
also suggested by the absence of diurnal variation of plasma
aldosterone concentration, whereas plasma cortisol concentra-
tion varies as in normal individuals [29].
Why stimulation by the renin-angiotensin system should be
more effective in maintaining aldosterone secretory responsive-
ness to ACTH than the stimulus provided by potassium is not
immediately apparent. Angiotensin II and potassium have been
shown to cause similar alterations in phospholipid metabolism
in the zona glomerulosa [45] and to increase the conversion of
cholesterol to 5 pregnenolone [46, 47]. There are also data
suggesting that both may act on later steps in steroidogenesis,
that is, the conversion of desoxycorticosterone to corticoste-
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Weight, kg 49.2 49.0 48.2 47.2 46.9
160 140 142 60 120
BP, mmHG ioo io o o o-
Patient no. 17
Weight,kg 52.2 51.1 50.6 50.6 50.5 50.7 50.5
152 108 100 90 100 96 112
BP,mmHG lao - - a o ao
Patient no. 18
100
— I U U I I
Weight, kg 48.3 48.2 47.9 48.0 47.6 46.9
160 150 140 150 140 140
BP,mmHG
-- -oo- -ao
Fig. 2. One-hour integrated plasma aldosterone (ng/dl) (•), cortisol
(g/dl) (A) and ACTH pg/mi) (•) concentrations, blood pressure and
body weight during volume-depleting hemodialysis in chronically an-
ephric subjects.
rone and the subsequent conversion of this precursor to aldos-
terone [48, 49]. Although angiotensin II and potassium have
been reported to produce similar morphologic changes in the
zona glomerulosa [50—531, differences in experimental design
make it difficult to make a valid comparison of these changes.
Studies to assess the effect of angiotensin II have been per-
formed after several weeks of stimulation, whereas only the
acute effects of increased potassium have been reported.
Volume-related changes in plasma cortisol concentration
which occurred in chronically anephric subjects, as well as
recently nephrectomized subjects, were associated closely with
changes in plasma ACTH concentration and negatively corre-
lated with changes in diastolic blood pressure. These relation-
ships are consistent with the proposed mechanism that relates
changes in ACTH and cortisol secretion to changes in arterial
and/or right atrial pressure [18—20, 22, 23, 54—56]. Studies
suggesting that angiotensin 11 may increase cortisol secretion,
either directly [24] or by stimulating ACTH secretion [25, 26],
have also been reported. Maran and Yates reported that stimu-
', I I I I I I •
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10
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Fig. 3. One-hour integrated plasma aldosterone (ng/dl) (•), cortisol
(g/dl) (A) and ACTH (pg/mi) () concentrations, blood pressure and
body weight during volume-depleting hemodialysis in three recently
nephrectomized subjects, 19, 20, and 21, and during hemodialysis
without volume depletion in one recently nephrectomized subject (no.
22).
lation of cortisol secretion by intravenously administered angio-
tensin II could be inhibited in unanesthetized dogs by pretreat-
ment of the animals with dexamethasone [25]. These investiga-
tors also reported that cortisol secretion could be increased by
intrapituitary infusions of angiotensin II, presumably as a
consequence of direct stimulation of ACTH release. Evidence
that angiotensin II may stimulate the release of corticotropin-
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releasing factor from the median eminence of the hypothalamus
has also been reported [57]. Increases in plasma ACTH and
corticosteroid concentrations, which were highly correlated,
were observed during and following intravenous infusions of
angiotensin II in studies reported by Ramsay et al [26].
Although the data from our studies do not exclude the
possibility that angiotensin Il-mediated stimulation of ACTH
secretion may act in conjunction with other mechanisms to
increase cortisol secretion during volume depletion, it is evident
that stimulation by angiotensin II is not a necessary prerequisite
for this response. Plasma cortisol concentrations significantly
increased during volume-depleting hemodialysis in chronically
anephric subjects, despite the prolonged absence of a function-
ing renin-angiotensin system.
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